PIES & SIDES DEEP SOUTH TOMATO PIE, INGREDIENTS: SLICED TOMATOES, PIMENTO CHEESE, BLEACHED FOUR, MILK PRODUCTS, SPICES. CONTAINS: SOY, FI...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1136-2024.
The firm was notified that the label did not list any sub ingredients. The product contains pimento cheese which is made with mayonnaise which may include eggs. Undeclared eggs.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1136-2024.
Recall ongoing. Follow firm instructions.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Robeson Enterprises or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1136-2024.
Robeson Enterprises
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Robeson Enterprises Recall FAQ
Robeson Enterprises is the subject of a dairy safety report: PIES & SIDES DEEP SOUTH TOMATO PIE, INGREDIENTS: SLICED TOMATOES, PIMENTO CHEESE, BLEACHED FOUR, MILK PRODUCTS, SPICES. CONTAINS: SOY, FI.... The notice was published on March 26, 2024 by the U.S. Food and Drug Administration (FDA). Approximately 3,000 units are potentially affected.